Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | JNK-IN-11 | 0.3 | uM | Visfatin | 1 | ng/mL | 2 | FGF Basic | 35.5 | 36 | |
0 | FGF Basic | 31.0 | 45 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 48.0 | 57 | ||||
RA2159 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 39.0 | 61 | |
RA2159 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 38.0 | 63 | |
RA2159 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 39.0 | 59 | |
RA2159 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 35.0 | 49 | |
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 40.0 | 44 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 45.0 | 42 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 40.0 | 43 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 44.5 | 50 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 48.0 | 32 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 49.0 | 35 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | FGF Basic | 40.0 | 49 | |
0 | FGF Basic | 31.5 | 72 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 51.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 46.0 | 66 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 34.0 | 66 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 46.0 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 48.0 | 89 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 42.0 | 81 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 57.5 | 78 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 51.0 | 72 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 50.0 | 64 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 58.5 | 64 |